Qsymia

Generic name: Phentermine And Topiramate
Drug class: Anorexiants

Usage of Qsymia

Qsymia contains a combination of phentermine and topiramate in an extended-release capsule. Phentermine is an appetite suppressant similar to an amphetamine. Topiramate is typically used as a seizure medication, also called an anticonvulsant.

Qsymia is used together with diet and exercise to help some adults and children 12 years and older with obesity, or some overweight adults who also have weight-related medical problems such as diabetes, high cholesterol, or high blood pressure, to lose weight and keep the weight off.

Qsymia will not treat any of these underlying conditions. Keep using any other medicines your doctor has prescribed to treat these conditions.

Qsymia side effects

Get emergency medical help if you have signs of an allergic Reaction to Qsymia: (hives; difficult breathing; swelling in your face or throat), or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), depressed, or have thoughts about suicide or hurting yourself.

Call your doctor at once if you have:

unusual changes in mood or behavior;

confusion, trouble concentrating, problems with speech or memory;

fast or pounding heartbeats while you are resting;

a seizure;

signs of a kidney stone - severe pain in your side or lower back, painful or difficult urination; or

signs of too much acid in your blood - loss of appetite, tiredness, thinking problems, irregular heartbeats.

Common Qsymia side effects may include:

joint pain, ankle sprain;

flu-like symptoms;

dizziness;

constipation;

numbness or tingly feeling;

sleep problems (insomnia);

dry mouth, changes in your sense of taste; or

mood changes, feelings of low self-worth, loss of interest in things you once enjoyed, thoughts about hurting yourself.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Qsymia

Do not use Qsymia if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, Rasagiline, Selegiline, tranylcypromine, and others.

You should not use Qsymia if you are allergic to phentermine or topiramate, or if you have:

glaucoma;

overactive thyroid; or

if you are pregnant or may become pregnant.

You may need to have a negative pregnancy test before starting this treatment. Do not use Qsymia if you are pregnant. Stop taking this medicine and call your doctor right away if you become pregnant.

Topiramate may increase the risk of cleft lip and palate in a newborn. This birth defect occurs early in pregnancy, and can develop even before you know you are pregnant. Weight loss during pregnancy also can harm an unborn baby, even if you are overweight. Use effective birth control to prevent pregnancy while you are using Qsymia.

Qsymia is not FDA-approved for use by anyone younger than 12 years old.

To make sure Qsymia is safe for you, tell your doctor if you have:

heart problems, high blood pressure;

a heart attack or stroke;

diabetes (weight loss may cause low blood sugar);

metabolic acidosis (too much acid in your blood);

soft or brittle bones (osteomalacia, osteopenia, osteoporosis);

kidney disease, kidney stones, or dialysis;

liver disease;

mood problems, depression, or suicidal thoughts or actions;

an allergy to aspirin or yellow dye (tartrazine):

a seizure; or

chronic diarrhea.

Topiramate can increase the level of acid in your blood (metabolic acidosis). This can weaken your bones, cause kidney stones, or cause growth problems in children or harm to an unborn baby. You may need blood tests to make sure you do not have metabolic acidosis.

Some people have thoughts about suicide while taking topiramate. Your doctor will need to check your progress at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.

You should not breast-feed while using Qsymia.

Relate drugs

How to use Qsymia

Usual Adult Dose of Qsymia for Weight Loss:

-Initial dose: Take one capsule of the lowest dose (phentermine 3.75 mg/topiramate 23 mg extended-release) orally once a day in the morning for the first 14 days. -Maintenance dose: After 14 days, take one capsule of the recommended dose (phentermine 7.5 mg/topiramate 46 mg extended-release) orally once a day in the morning. Comments: -Weight loss should be evaluated after 12 weeks with phentermine 7.5 mg/topiramate 46 mg extended-release. If a patient has not lost at least 3% of baseline body weight increase the doSage to phentermine 11.25 mg/topiramate 69 mg) orally once daily for 14 days; followed by an increase in the dosage to phentermine 15 mg/topiramate 92 mg orally once daily. Weight loss should be evaluated after 12 weeks with phentermine 15 mg/topiramate 92 mg. If a patient has not lost at least 5% of baseline body weight, discontinue treatment, as it is unlikely that the patient will achieve and sustain clinically meaningful weight loss at this dose. Discontinue phentermine 15 mg/topiramate 92 mg dose gradually by taking once daily every other day for at least one week prior to stopping treatment altogether. Use: Adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) OR 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia.

Usual Pediatric Dose of Qsymia for Weight Loss:

-Initial dose: Take one capsule of the lowest dose (phentermine 3.75 mg/topiramate 23 mg extended-release) orally once a day in the morning for the first 14 days.

-Maintenance dose: After 14 days, take one capsule of the recommended dose (phentermine 7.5 mg/topiramate 46 mg extended-release) orally once a day in the morning.

Comments: -Weight loss should be evaluated after 12 weeks with phentermine 7.5 mg/topiramate 46 mg extended-release. If a pediatric patient has not lost at least 3% of baseline BMI, increase the dosage to phentermine 11.25 mg/topiramate 69 mg) orally once daily for 14 days; followed by an increase in the dosage to phentermine 15 mg/topiramate 92 mg orally once daily. Weight loss should be evaluated after 12 weeks with phentermine 15 mg/topiramate 92 mg. If a pediatric patient has not lost at least 5% of baseline BMI, discontinue treatment, as it is unlikely that the patient will achieve and sustain clinically meaningful weight loss at this dose. Discontinue phentermine 15 mg/topiramate 92 mg dose gradually by taking once daily every other day for at least one week prior to stopping treatment altogether.

Use: Adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in pediatric patients aged 12 years and older with BMI in the 95th percentile or greater standardized for age and sex.

Warnings

Do not use Qsymia if you are pregnant or if you become pregnant. This medicine may increase the risk of a birth defect called cleft lip and palate in a newborn.

You should not take Qsymia if you are allergic to phentermine (Adipex-P, Oby-Cap, Suprenza, T-Diet, Zantryl) or topiramate (Topamax), or if you have glaucoma or overactive thyroid.

Before you take Qsymia, tell your doctor if you have high blood pressure, heart disease, diabetes, liver or kidney disease, low blood levels of potassium, or if you have HAD a heart attack or stroke in the past 6 months.

Phentermine may be habit-forming and should be used only by the person for whom it was prescribed. Keep the medication in a secure place where others cannot get to it. Do not stop taking Qsymia suddenly, or you could have a seizure (convulsions). You may need to use less and less before you stop the medication completely. Ask your doctor how to avoid seizures when you stop using Qsymia

Topiramate may cause vision problems that can be permanent if not treated quickly. Call your doctor right away if you have a sudden decrease in vision.

Some people have thoughts about suicide while taking topiramate. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.

Qsymia can increase your resting heart rate. Tell your doctor if you have fast or pounding heartbeats while you are resting.

What other drugs will affect Qsymia

Qsymia can cause irregular vaginal bleeding while you are taking birth control pills. This should not make the pills less effective in preventing pregnancy.

Using this medicine with other drugs that make you drowsy can worsen this effect. Ask your doctor before using opioid medication, a sleeping pill, a muscle relaxer, or medicine for anxiety or seizures.

Tell your doctor about all your other medicines, especially:

acetazolamide;

methazolamide;

zonisamide;

Valproic acid or divalproex sodium (Depakene or Depakote)

birth control pills;

a diuretic or "water pill";

insulin or oral diabetes medicine; or

medicines that impair or decrease your thinking, concentration, or muscle coordination.

This list is not complete. Other drugs may interact with phentermine and topiramate, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.